Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells

International Journal of Cancer

Volumn 133, Issue 7, 2013, Pages 1631-1642

  Honegger, Anja ^a   Leitz, Jenny ^a   Bulkescher, Julia ^a   Hoppe Seyler, Karin ^a   Hoppe Seyler, Felix ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cervical cancer; exosomes; HPV; senescence; Survivin; tumor virology

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN 1; LIVIN; PROTEIN E6; PROTEIN E7; PROTEIN P53; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CANCER CELL; CELL ORGANELLE; CHMP4C GENE; CONTROLLED STUDY; E6 GENE; E7 GENE; EXOSOME; EXTRACELLULAR MICROVESICLE; GENE; GENE EXPRESSION; GENE SILENCING; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN INDUCTION; RNA INTERFERENCE; SENESCENCE; TSAP6 GENE; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

CERVICAL CANCER; EXOSOMES; HPV; SENESCENCE; SURVIVIN; TUMOR VIROLOGY;

ACETYLCHOLINESTERASE; CELL AGING; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EXOSOMES; HELA CELLS; HUMAN PAPILLOMAVIRUS 18; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; ONCOGENE PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880295341     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28164     Document Type: Article

References (65)

1. zur Hausen H,. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-50.
2. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, et al. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 1988; 48: 3780-6.
3. McLaughlin-Drubin ME, Munger K,. Oncogenic activities of human papillomaviruses. Virus Res 2009; 143: 195-208.
4. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36.
5. Klingelhutz AJ, Foster SA, McDougall JK,. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79-82.
6. McLaughlin-Drubin ME, Munger K,. The human papillomavirus E7 oncoprotein. Virology 2009; 384: 335-44.
7. Thery C, Zitvogel L, Amigorena S,. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569-79.
8. Simons M, Raposo G,. Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009; 21: 575-81.
9. Thery C, Ostrowski M, Segura E,. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-93.
10. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-9.
11. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-6.
12. Simpson RJ, Lim JW, Moritz RL, et al. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009; 6: 267-83.
13. Keller S, Ridinger J, Rupp AK, et al. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 2011; 9: 86.
14. Shao H, Chung J, Balaj L, et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 2012; 18: 1835-40.
15. Meckes DG, Jr, Shair KH, Marquitz AR, et al. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci USA 2010; 107: 20370-5.
16. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 2010; 107: 6328-33.
17. Altieri DC,. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008; 8: 61-70.
18. Khan S, Jutzy JM, Aspe JR, et al. Survivin is released from cancer cells via exosomes. Apoptosis 2011; 16: 1-12.
19. Kuner R, Vogt M, Sultmann H, et al. Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses. J Mol Med (Berl) 2007; 85: 1253-62.
20. Butz K, Ristriani T, Hengstermann A, et al. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003; 22: 5938-45.
21. Parsons BD, Schindler A, Evans DH, et al. A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay. PLoS One 2009; 4: e8471.
22. Jackson AL, Linsley PS,. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 2010; 9: 57-67.
23. Butz K, Geisen C, Ullmann A, et al. Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress. Oncogene 1998; 17: 781-7.
24. Wagener N, Crnkovic-Mertens I, Vetter C, et al. Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney. Br J Cancer 2007; 97: 1271-6.
25. Crnkovic-Mertens I, Semzow J, Hoppe-Seyler F, et al. Isoform-specific silencing of the Livin gene by RNA interference defines Livin β as key mediator of apoptosis inhibition in HeLa cells. J Mol Med (Berl) 2006; 84: 232-40.
26. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
27. Savina A, Vidal M, Colombo MI,. The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci 2002; 115: 2505-15.
28. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-7.
29. Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; Chapter 3: Unit 3.22.
30. Thery C, Boussac M, Veron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001; 166: 7309-18.
31. Mathivanan S, Ji H, Simpson RJ,. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73: 1907-20.
32. Casciola-Rosen LA, Anhalt G, Rosen A,. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30.
33. Bobrie A, Colombo M, Krumeich S, et al. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J Extracellular Vesicles 2012; 1: 18397.
34. Lehmann BD, Paine MS, Brooks AM, et al. Senescence-associated exosome release from human prostate cancer cells. Cancer Res 2008; 68: 7864-71.
35. Hall AH, Alexander KA,. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 2003; 77: 6066-9.
36. Holland D, Hoppe-Seyler K, Schuller B, et al. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res 2008; 68: 9964-72.
37. Goodwin EC, Yang E, Lee CJ, et al. Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci USA 2000; 97: 10978-83.
38. Amzallag N, Passer BJ, Allanic D, et al. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem 2004; 279: 46104-12.
39. Yu X, Harris SL, Levine AJ,. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 2006; 66: 4795-801.
40. Lespagnol A, Duflaut D, Beekman C, et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ 2008; 15: 1723-33.
41. Yu X, Riley T, Levine AJ,. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J 2009; 276: 2201-12.
42. Khan S, Jutzy JM, Valenzuela MM, et al. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One 2012; 7: e46737.
43. Borbely AA, Murvai M, Konya J, et al. Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol 2006; 87: 287-94.
44. Hoffman WH, Biade S, Zilfou JT, et al. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002; 277: 3247-57.
45. Taylor DD, Gercel-Taylor C,. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol 2011; 33: 441-54.
46. Henderson MC, Azorsa DO,. The genomic and proteomic content of cancer cell-derived exosomes. Front Oncol 2012; 2: 38.
47. Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012; 14: 677-85.
48. Nazarenko I, Rana S, Baumann A, et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 2010; 70: 1668-78.
49. van Niel G, Charrin S, Simoes S, et al. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev Cell 2011; 21: 708-21.
50. Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008; 10: 619-24.
51. Antonyak MA, Li B, Boroughs LK, et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 2011; 108: 4852-7.
52. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18: 883-91.
53. Bobrie A, Colombo M, Raposo G, et al. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011; 12: 1659-68.
54. Pant S, Hilton H, Burczynski ME,. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012; 83: 1484-94.
55. Palmisano G, Jensen SS, Le Bihan MC, et al. Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies. Mol Cell Proteomics 2012; 11: 230-43.
56. Khan S, Aspe JR, Asumen MG, et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer 2009; 100: 1073-86.
57. Wells SI, Francis DA, Karpova AY, et al. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J 2000; 19: 5762-71.
58. Campisi J,. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685-705.
59. Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: 2853-68.
60. Acosta JC, Gil J,. Senescence: a new weapon for cancer therapy. Trends Cell Biol 2012; 22: 211-19.
61. Wu PC, Wang Q, Grobman L, et al. Accelerated cellular senescence in solid tumor therapy. Exp Oncol 2012; 34: 298-305.
62. Hoppe-Seyler F, Hoppe-Seyler K,. Emerging topics in human tumor virology. Int J Cancer 2011; 129: 1289-99.
63. Stern PL, van der Burg SH, Hampson IN, et al. Therapy of human papillomavirus-related disease. Vaccine 2012; 30 (Suppl 5): F71-F82.
64. Tan S, de Vries EG, van der Zee AG, et al. Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer. Curr Cancer Drug Targets 2012; 12: 170-84.
65. Xu D, Tahara H,. The role of exosomes and microRNAs in senescence and aging. Adv Drug Deliv Rev 2013; 65: 368-75.